• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类异戊二烯修饰与质膜关联:Ras致癌性的关键因素。

Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.

作者信息

Der C J, Cox A D

机构信息

La Jolla Cancer Research Foundation, California 92037.

出版信息

Cancer Cells. 1991 Sep;3(9):331-40.

PMID:1751286
Abstract

Association of ras protein with the plasma membrane is critical for its transforming activity. This association is promoted by a series of post-translational modifications that are signaled by the consensus C-terminal CAAX motif present in all ras proteins. The recent discovery that a 15-carbon isoprenoid (farnesyl) group, derived from an essential intermediate in cholesterol biosynthesis, is attached covalently to ras proteins has stimulated considerable interest and has suggested several important new directions for ras studies. In particular, one promising pharmacologic approach for antagonizing oncogenic ras activity in human malignancies would be to design specific inhibitors of the enzymes that catalyze ras processing and thereby interfere with ras protein association with the plasma membrane.

摘要

Ras蛋白与质膜的结合对其转化活性至关重要。这种结合由一系列翻译后修饰所促进,这些修饰由所有Ras蛋白中存在的共有C末端CAAX基序发出信号。最近发现,一种源自胆固醇生物合成必需中间体的15碳异戊二烯(法尼基)基团共价连接到Ras蛋白上,这引起了人们极大的兴趣,并为Ras研究提出了几个重要的新方向。特别是,一种在人类恶性肿瘤中拮抗致癌Ras活性的有前景的药理学方法是设计催化Ras加工的酶的特异性抑制剂,从而干扰Ras蛋白与质膜的结合。

相似文献

1
Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.类异戊二烯修饰与质膜关联:Ras致癌性的关键因素。
Cancer Cells. 1991 Sep;3(9):331-40.
2
The ras/cholesterol connection: implications for ras oncogenicity.
Crit Rev Oncog. 1992;3(4):365-400.
3
Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product.
Oncogene. 1988 Jun;2(6):533-7.
4
Rho family proteins and Ras transformation: the RHOad less traveled gets congested.Rho家族蛋白与Ras转化:鲜有人走的“RHO路”拥堵了。
Oncogene. 1998 Sep 17;17(11 Reviews):1415-38. doi: 10.1038/sj.onc.1202181.
5
An essential role for Rac in Ras transformation.Rac在Ras转化过程中的关键作用。
Nature. 1995 Mar 30;374(6521):457-9. doi: 10.1038/374457a0.
6
Post-translational processing and subcellular localization of the Ras-related Rap2 protein.
Oncogene. 1991 Oct;6(10):1835-42.
7
Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.类Ral GDP解离刺激因子(RGL)的Ras相互作用结构域可逆转v-Ras诱导的NIH3T3细胞转化及Raf-1激活。
Cancer Res. 1996 May 15;56(10):2387-92.
8
Critical role of Rho in cell transformation by oncogenic Ras.Rho在致癌性Ras诱导的细胞转化中的关键作用。
Oncogene. 1995 Jun 15;10(12):2289-96.
9
Interactions between Ras and Raf: key regulatory proteins in cellular transformation.Ras与Raf之间的相互作用:细胞转化中的关键调控蛋白。
Mol Reprod Dev. 1995 Dec;42(4):493-9. doi: 10.1002/mrd.1080420418.
10
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.Rit是一种非脂质修饰的Ras相关蛋白,它可使NIH3T3细胞发生转化,而不激活ERK、JNK、p38丝裂原活化蛋白激酶(MAPK)或PI3K/Akt信号通路。
Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836.

引用本文的文献

1
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.针对 HRAS 突变型横纹肌肉瘤的法尼基化作为一种新的治疗方法。
Oncogene. 2022 May;41(21):2973-2983. doi: 10.1038/s41388-022-02305-x. Epub 2022 Apr 22.
2
Statins: a repurposed drug to fight cancer.他汀类药物:一种用于抗癌的再利用药物。
J Exp Clin Cancer Res. 2021 Jul 24;40(1):241. doi: 10.1186/s13046-021-02041-2.
3
Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis.异戊烯化的c17orf37诱导丝状伪足形成以促进细胞迁移和转移。
J Biol Chem. 2011 Jul 22;286(29):25935-46. doi: 10.1074/jbc.M111.254599. Epub 2011 May 31.
4
Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.基于结构的设计与合成强效、乙二胺基的哺乳动物法尼基转移酶抑制剂作为抗癌药物。
J Med Chem. 2010 Oct 14;53(19):6867-88. doi: 10.1021/jm1001748.
5
Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity.多个序列元件促进Chp Rho GTP酶的亚细胞定位、膜结合及转化活性。
Mol Biol Cell. 2006 Jul;17(7):3108-21. doi: 10.1091/mbc.e05-09-0896. Epub 2006 Apr 26.
6
Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.法尼基化还是香叶基香叶基化?用于体内外检测蛋白质异戊二烯化的高效检测方法。
BMC Biochem. 2006 Feb 28;7:6. doi: 10.1186/1471-2091-7-6.
7
Organosulfur compounds from alliaceae in the prevention of human pathologies.葱属植物中的有机硫化合物在预防人类疾病方面的作用。
Biomed Pharmacother. 2004 Apr;58(3):183-93. doi: 10.1016/j.biopha.2004.01.004.
8
Palmitoylation and plasma membrane localization of Ras2p by a nonclassical trafficking pathway in Saccharomyces cerevisiae.酵母中通过非经典运输途径实现Ras2p的棕榈酰化和质膜定位
Mol Cell Biol. 2003 Sep;23(18):6574-84. doi: 10.1128/MCB.23.18.6574-6584.2003.
9
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.异戊二烯化抑制剂可阻止传染性丁型肝炎病毒颗粒的产生。
J Virol. 2002 Oct;76(20):10465-72. doi: 10.1128/jvi.76.20.10465-10472.2002.
10
Conformational analysis of a farnesyltransferase peptide inhibitor, CVIM.
J Comput Aided Mol Des. 2000 May;14(4):369-82. doi: 10.1023/a:1008175919794.